Results 121 to 130 of about 4,041 (164)

[Stem cell therapy for premature ovarian insufficiency: a review of clinical evidence and therapeutic strategies]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Cheng Z, Lai D.
europepmc   +1 more source

[Activation of JAK/STAT in ovarian high-grade serous cancers and its prognostic significance]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2023
Yang J, DU J, Wang YX, Liu CR.
europepmc   +1 more source

[Advances in ovarian tissue cryopreservation and transplanta-tion for fertility preservation in prepubertal patients]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Cheng J, Ruan X, DU J, Jin F, Gu M.
europepmc   +1 more source

[A Study on the Association Between Various Insulin Resistance Assessment Indices and IVF-ET Outcomes in Patients With Polycystic Ovary Syndrome]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Liu Y, Hu Z, Han J, Gao R, Qin L.
europepmc   +1 more source

[Effects of bisphenol A on apoptosis of ovarian preantral follicular granulosa cells and ovarian development in mice]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2021
Liang M, Zhou J, Sun X, He C, Zhang K, Hu K.   +5 more
europepmc   +1 more source

[Gandou Bushen decoction ameliorates ovarian injury in murine hepatolenticular degeneration via the AGE/RAGE/NF-κB signaling pathway]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Jiang P, Wu L, Han H.
europepmc   +1 more source

Efficiency of Chinese medicine Bushen Huatan formula for treatment of polycystic ovary syndrome in mice via regulating gut microbiota and PPARγ pathway. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023
Cui M, Hong Y, Huang J, Liu K, Chen J, Tan Y, Nie X.   +6 more
europepmc   +1 more source

[Research Progress in the Pathogenesis of Polycystic Ovary Syndrome]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Gao H, Qian B, Ni Y, Sun L, Fu J.
europepmc   +1 more source

Research progress in the treatment of partial platinum-sensitive recurrent ovarian cancer. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2021
Zhu M, Wang J, Wuna Y, Wang Y, Li H.
europepmc   +1 more source

cDNA 微阵列和组织微阵列对卵巢上皮性肿瘤基因的表达

Zhongshan Daxue xuebao. Yixue kexue ban, 2004
【目的】结合cDNA微阵列和RNA与冰冻组织微阵列原位杂交的方法以寻找新的特异性卵巢癌候选癌基因,为卵巢癌的早期诊断和治疗提供理论依据。【方法】利用cDNA微阵列筛选在所有3种上皮性卵巢肿瘤中(卵巢浆液性交界性肿瘤、卵巢浆液性腺癌和卵巢子宫内膜样腺癌)显示有意义表达的基因,由RNA与冰冻组织微阵列原位杂交证实其结果。【结果】28个基因在>70%卵巢肿瘤中显示出高表达,18个基因在>70%卵巢肿瘤中低表达;干扰素诱导的转膜蛋白1(IITP1)被进一步用于RNA与冰冻组织微阵列原位杂交研究 ...
doaj